Multiple Sclerosis Clinical Trial
Official title:
Internet-based Physical Activity Promotion and Exercise Prescription for People With Multiple Sclerosis. A Feasibility Study.
Verified date | April 2020 |
Source | University of Erlangen-Nürnberg |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study evaluates the feasibility of a 12-week internet-based exercise and physical activity counseling intervention for people with Multiple Sclerosis (MS).
Status | Completed |
Enrollment | 26 |
Est. completion date | August 16, 2019 |
Est. primary completion date | August 16, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - diagnosed Multiple Sclerosis (McDonald criteria) - expanded Disability Status Scale between 0 - 6.5 - neurologically stable (no exacerbation within 30 days prior to enrollment) - internet access (WiFi) - basic knowledge on handling personal computer and the internet - owning a smartphone with the operating system Android or IOS and with access to Google Play Store or Apple App score - ability to read, write and comprehend as well as communicate electronically - not regularly physically active (more than 30 minutes twice a week with a moderate intensity (includes aerobic training, resistance training and other sports e.g. Tennis; excludes physiotherapy, physical activity during work or household, grocery shopping, gardening, walking the dog etc.) Exclusion Criteria: - clinically relevant cardiovascular diseases - cortisone therapy in the last 30 days - cognitive impairment - severe impairment of hand function (ataxia or paresis impeding the use of a smartphone app or smartwatch) - severe internal, orthopaedic and metabolic diseases that restrict mobility |
Country | Name | City | State |
---|---|---|---|
Germany | Neurological Rehabilitation Center Quellenhof | Bad Wildbad | Baden-Wuerttemberg |
Germany | Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) | Erlangen | |
Germany | Klinikum Würzburg Mitte gGmbH | Würzburg | Bavaria |
Lead Sponsor | Collaborator |
---|---|
University of Erlangen-Nürnberg | Aktion Multiple Sklerose Erkrankter, Landesverband der DMSG in Baden-Württemberg (AMSEL) e.V., Center for Telemedicine Bad Kissingen (ZTM), Klinikum Würzburg Mitte GmbH, Medi train - Zentrum für Gesundheitssport, Sport- und Physiotherapie, motionNET systems Limited, Neurological Rehabilitation Center Quellenhof, proMX GmbH Nürnberg |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Acceptability of the Intervention and participants' experiences (focus groups) | Focus groups (1,5 hrs) with participants to determine extent to which they perceived intervention as appropriate. | 1 week after the end of the intervention | |
Primary | Compliance with intervention protocol (completed training sessions and e-learning modules) | Completed training sessions and e-learning modules will be documented for each participant with the interventions mobile app and e-learning course. | over the 12 weeks of intervention | |
Primary | Acceptability of the Intervention and participants' experiences (interviews) | With those participants that cannot take part in the focus groups, semistructured interviews (30 min) will be conducted to determine extent to which participants' perceived intervention as appropriate. Interview questions are based on focus group questions. The wording is slightly adapted to fit the interview situation. | 1 week after the end of the intervention | |
Secondary | Changes in objectively measures physical activity | The physical activity level of participants is measured over a 7 day period with the accelerometer Actigraph GT3X+. The Actigraph GT3X+ measures acceleration on three axes. Steps per day, physical activity per day (activity counts) and time in moderate and vigorous physical activity per day will be calculated. | 1 week before start of the intervention (T0), 1 week after the end of the intervention (T1) | |
Secondary | Changes in subjectively measured physical activity: European Health Interview Survey-Physical Activity Questionnaire (EHIS-PAQ) | 8-item questionnaire to assess time spent for work related physical activity, physical activity for transportation (walking, biking), muscle strengthening exercises and sports, fitness or recreational physical activity during a typical week. | 1 week before start of the intervention (T0), 1 week after end of the intervention (T1) | |
Secondary | Würzburger Fatigue Inventory for MS (WEIMuS) | This questionnaire contains 17 items that form a physical and cognitive subscale. The total score ranges from zero to a maximum of 68 points (maximum fatigue). The cut-off value for the presence of fatigue is above 32. | 1 week before start of the intervention (T0), 1 week after the end of the intervention (T1) | |
Secondary | Allgemeine Depressionsskala (ADS-L) | German version of the Center for Epidemiologic Studies Depression Scale, 20 item questionnaire. Each item is rated on a 4-point Likert scale. Answers are scored from 0 to 3. The scores for all items are added up to receive the total score. The total score ranges from 0 to 60 with higher scores representing higher levels of depression. | 1 week before start of the intervention (T0), 1 week after the end of the intervention (T1) | |
Secondary | Multiple Sclerosis Walking Scale-12 | 12-item questionnaire measuring self reported walking ability. Each item is answered on a 5-point Likert scale. Answers are scored from 1 to 5. The scores for all items are added up to receive a total score. The total score ranges from 12 to 60 with higher scores representing higher levels of depression. As a last step the total score is transformed into the walk12-score ranging from 0 to 100 ((total score -12)/48 x 100 = walk12-score). | 1 week before start of the intervention (T0), 1 week after the end of the intervention (T1) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT02845635 -
MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
|